Skip Navigation

LABORATORIOS ROVI

Profile

ROVI is a pan-European pharmaceutical company specializing and engaging in the research, development, contract manufacturing and marketing of small molecules and biological specialties. The company, in a continuous international expansion process, has subsidiaries in Portugal, Germany, the United Kingdom, Italy, France and Poland and has a diversified marketing portfolio of more than 40 products, among which its flagship product, Bemiparin, already present in 89 countries all over the world, should be highlighted. Likewise, in 2017, ROVI commenced the marketing of its enoxaparin biosimilar, developed in-house, in Europe and it is already marketed in 38 countries. ROVI continues to develop the ISM® Platform technology, a leading-edge line of research in the field of prolonged drug release with proven advantages. For more information, please visit www.rovi.es

Research

220 KBMorningstar - Quantitative Report (21 November 2024 08:16)

Video Gallery

Javier López-Belmonte, VP y CFO
ROVI

29/10/2020

Resultados 2019
Javier López-Belmonte
Vicepresidente y CFO 

27/02/2020

Javier Pérez-Belmonte
Director Financiero 
R
OVI

07/02/2019